Skip to main content
ArticleOPEN ACCESS

Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design (Nature Reviews Drug Discovery, (2021), 10.1038/s41573-021-00252-y)

Nature Reviews Drug Discovery
DOI: 10.1038/s41573-021-00303-4
16Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Errors in the description of side effects reported for the kinase inhibitor deucravacitinib have been corrected.

Cite

CITATION STYLE

APA

Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021, October 1). Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design (Nature Reviews Drug Discovery, (2021), 10.1038/s41573-021-00252-y). Nature Reviews Drug Discovery. Nature Research. https://doi.org/10.1038/s41573-021-00303-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free